関連する実験動画
Updated: Jan 7, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
1型糖尿病におけるインスリンボーラス計算の開発:実世界データ、デジタルツイン、機械学習に基づくフレームワーク
Objective:
Precise mealtime insulin bolus (MIB) dosing is essential in type 1 diabetes (T1D) to minimize glucose excursions from carbohydrate intake. Traditional MIB formulas, based on glucose concentration at mealtime, are suboptimal and do not exploit real-time data from continuous glucose monitoring (CGM). Existing methods that incorporate CGM data often rely on empirical rules or are developed in-silico, limiting their applicability to real-world conditions. This work investigates a framework combining machine learning (ML) algorithms, digital twins (DTs) and real-world data, to improve the assessment, tuning, and development of MIB dosing algorithms.
Methods:
We utilized ReplayBG, a DT for T1D, to: i) evaluate a published linear ML model (Noaro et al.), originally developed in-silico, on real-world data from 30 free-living subjects; ii) recalibrate this model to fit the real-world dataset; and iii) train and test nonlinear gradient-boosting models (XGBoost, LightGBM) developed entirely on real data through DT simulations.
Results:
Progressing to DT-enhanced models, we observed improvements in glucose control. The recalibrated linear and nonlinear models increased time-in-range (up to 80.6% with LightGBM vs. 75.6% for Noaro et al.) and reduced time-above-range. Risk metrics reflecting hypo/hyperglycemia also improved.
Conclusions:
These findings demonstrate that a DT-based framework grounded in real-world data supports both the refinement and development of bolus calculators, achieving performance gains beyond the original in-silico model.
Significance:
DTs allow the use real-world data to develop, validate and extend the domain of validity of new MIB formulas, paving the way to practical applications of ML tailored solutions for T1D.
関連する概念動画
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Insulin Formulations: Types and Delivery
Short-acting insulins are divided into...
Insulin: Biosynthesis, Chemistry, and Preparation
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

